By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


Start Up

Company News
Xbiotech To Present Positive Preliminary Survival Data On Xilonix At The 18th European Society Of Medical Oncology’s World Congress On Gastrointestinal Cancer 5/24/2016 8:17:38 AM
XBiotech Provides First Quarter 2016 Corporate And Clinical Update 5/18/2016 10:20:33 AM
XBiotech Names Industry Veteran Dawn McCollough To Head Clinical Operations 5/16/2016 8:23:42 AM
XBiotech USA (XBIT) To Provide First Quarter 2016 Business Update On May 18 5/11/2016 10:11:32 AM
XBiotech USA (XBIT) Appoints Amgen (AMGN) Veteran Scott Whitehurst As Chief Financial Officer 5/3/2016 7:50:45 AM
XBiotech USA (XBIT) To Present Pivotal Phase III Data On Xilonix At European Society Of Medical Oncology’s World Congress On Gastrointestinal Cancer 4/19/2016 7:57:20 AM
European Medicines Agency Grants Accelerated Assessment Of Marketing Authorization Application For Xilonix, XBiotech USA (XBIT)h’s True Human Therapeutic Antibody Treatment For Advanced Colorectal Cancer 4/4/2016 8:17:07 AM
Xbiotech To Deliver Presentation On Novel Study Design And Phase III Results From European Study On Xilonix During Meeting At The European Parliament 3/2/2016 7:48:38 AM
XBiotech USA (XBIT) Engages In Research For Heart Attack Antibody Therapy 2/19/2016 11:08:03 AM
Xbiotech Announces Agreement With The NCIC Clinical Trials Group To Collaborate On Phase II Study In Non-Small Cell Lung Cancer (NSCLC) 12/11/2015 7:11:42 AM